Related Experiment Videos
Rat urinary bladder epithelial lesions induced by acrolein.
T Sakata1, R A Smith, E M Garland
1Department of Pathology & Microbiology, University of Nebraska Medical Center, Omaha.
Summary
Systemic administration of acrolein, a toxic compound in cigarette smoke, caused urinary bladder hyperplasia in rats. Higher doses significantly increased cell proliferation in the bladder lining.
Area of Science:
- Toxicology
- Urothelial Biology
- Carcinogenesis Research
Background:
- Acrolein is a toxicant found in cigarette smoke and a cyclophosphamide metabolite.
- Direct bladder instillation of acrolein causes cytotoxicity.
- Systemic effects of acrolein on the urinary bladder are not well understood.
Purpose of the Study:
- To investigate the effects of systemically administered acrolein on the rat urinary bladder.
- To determine if acrolein reaches the bladder and induces cellular changes after oral or intraperitoneal exposure.
Main Methods:
- Male F344 rats were administered acrolein via intragastric or intraperitoneal routes.
- Initial toxicity assessment at 25 mg/kg.
- Dose-response study with intraperitoneal injections (0.5–6 mg/kg) followed by autoradiography to measure mucosal labeling index.
Main Results:
- A dose of 25 mg/kg acrolein was highly toxic, causing significant mortality.
- Intraperitoneal administration of 6 mg/kg acrolein led to a significant increase in the urinary bladder mucosal labeling index.
- Focal simple hyperplasia was observed in surviving rats after initial high-dose intraperitoneal injection.
Conclusions:
- Systemic administration of acrolein, particularly via intraperitoneal injection, leads to significant proliferation of the urinary bladder mucosa.
- Acrolein reaches the urinary bladder in sufficient quantities after systemic exposure to induce a proliferative response.
- These findings suggest a potential role for acrolein in chemically induced bladder cancer.